1014 related articles for article (PubMed ID: 18171250)
1. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
[TBL] [Abstract][Full Text] [Related]
2. [Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l].
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
Rev Esp Quimioter; 2008 Jun; 21(2):93-8. PubMed ID: 18509768
[TBL] [Abstract][Full Text] [Related]
3. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.
Hidayat LK; Hsu DI; Quist R; Shriner KA; Wong-Beringer A
Arch Intern Med; 2006 Oct; 166(19):2138-44. PubMed ID: 17060545
[TBL] [Abstract][Full Text] [Related]
4. Predictors of high vancomycin MIC values among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Lodise TP; Miller CD; Graves J; Evans A; Graffunder E; Helmecke M; Stellrecht K
J Antimicrob Chemother; 2008 Nov; 62(5):1138-41. PubMed ID: 18694905
[TBL] [Abstract][Full Text] [Related]
5. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia?
de Sanctis JT; Swami A; Sawarynski K; Gerasymchuk L; Powell K; Robinson-Dunn B; Carpenter CF; Sims MD
Diagn Mol Pathol; 2011 Sep; 20(3):184-8. PubMed ID: 21817905
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
Ahmad NM; Rojtman AD
Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
[TBL] [Abstract][Full Text] [Related]
7. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ
Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.
Soriano A; Martínez JA; Mensa J; Marco F; Almela M; Moreno-Martínez A; Sánchez F; Muñoz I; Jiménez de Anta MT; Soriano E
Clin Infect Dis; 2000 Feb; 30(2):368-73. PubMed ID: 10671343
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Gao W; Christiansen KJ; Coombs GW; Johnson PD; Howden BP
J Infect Dis; 2011 Aug; 204(3):340-7. PubMed ID: 21742831
[TBL] [Abstract][Full Text] [Related]
11. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
[TBL] [Abstract][Full Text] [Related]
12. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
13. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
Yoon YK; Kim JY; Park DW; Sohn JW; Kim MJ
J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036
[TBL] [Abstract][Full Text] [Related]
14. Early empirical glycopeptide therapy for patients with methicillin-resistant Staphylococcus aureus bacteraemia: impact on the outcome.
Fang CT; Shau WY; Hsueh PR; Chen YC; Wang JT; Hung CC; Huang LY; Chang SC
J Antimicrob Chemother; 2006 Mar; 57(3):511-9. PubMed ID: 16443700
[TBL] [Abstract][Full Text] [Related]
15. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
16. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
[TBL] [Abstract][Full Text] [Related]
17. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
19. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
[TBL] [Abstract][Full Text] [Related]
20. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
